Skip to main content

Connective tissue diseases

Highlights

Child being vaccinated (symbolic image with models)

18-10-2018 | Infection | Editorial | Article

Vaccination in children and adolescents with rheumatic conditions

In this editorial, the authors discuss the risks of live vaccination in children taking antirheumatic medications and how to manage these, as well as how health authorities can address decreasing vaccination coverage of the general public.

Pregnant woman_doctor with clipboard

16-10-2018 | Pregnancy | Editorial | Article

Planning and managing pregnancy in lupus patients

Megan Clowse discusses the importance of planning pregnancy in patients with lupus to avoid high-risk pregnancy, and outlines strategies to manage active lupus during pregnancy.

31-08-2018 | Immune checkpoint inhibitor-induced rheumatic disease | Review | Article

Rheumatic immune-related adverse events from cancer immunotherapy

Calabrese LH, Calabrese C, Cappelli LC. Nat Rev Rheumatol 2018. doi: 10.1038/s41584-018-0074-9

Doctor and calculator

07-09-2018 | Treatment | Feature | Article

At a glance: Common scores used in rheumatology

A quick-reference guide to the scores that are commonly used in clinical trials and daily rheumatology practice.

Bacteria

03-08-2018 | Sjögren’s syndrome | Highlight | News

Oral microbiome imbalance reported in Sjögren’s syndrome patients

Study results suggest that patients with primary Sjögren’s syndrome, and those with similar symptoms, may experience dysbiosis of the buccal mucosa microbiome.

Knee arthroplasty concept image (symbolic image with model)

11-07-2018 | Arthroplasty | Review | Article

Total joint arthroplasty in patients with inflammatory rheumatic diseases

Compagnoni R, Gualtierotti R, Randelli P. Adv Ther 2018. doi: 10.1007/s12325-018-0750-9

Patient with angioedema (used with permission)

27-06-2018 | Systemic lupus erythematosus | Case report | Article

Acquired angioedema in juvenile systemic lupus erythematosus: Case-based review

Tekin et al. report the case of a previously healthy 16-year-old girl with an acquired angioedema as a rare and initial presentation of systemic lupus erythematosus, and review the related literature.

Tekin ZE, Yener GO, Yüksel S. Rheumatol Int 2018. doi: 10.1007/s00296-018-4088-z

15-06-2018 | Systemic lupus erythematosus | EULAR 2018 | News

Baricitinib shows promise in SLE

The addition of once-daily baricitinib to standard background therapy could improve clinical outcomes in patients with systemic lupus erythematosus, phase II trial findings show.

Woman doing push ups (symbolic image with model)

12-06-2018 | Physical activity | View from the clinic | Article

Incorporating exercise in the treatment of lupus and other rheumatic diseases: It's time!

In this piece, Sarah Patterson and Patricia Katz discuss the benefits of exercise, and the barriers to increasing physical activity, in patients with systemic lupus erythematosus.

Lupus word cloud

03-05-2018 | Systemic lupus erythematosus | Review | Article

New trials in lupus and where are we going

In this article, the authors review progress in the field of clinical trials for systemic lupus erythematosus.

Thanou A, Merrill JT. Curr Rheumatol Rep 2018; 20: 34. doi: 10.1007/s11926-018-0745-1

Close-up of injection (symbolic image with model)

26-04-2018 | Systemic lupus erythematosus | Highlight | News

Promising results for subcutaneous belimumab in subset of SLE patients

Treatment with subcutaneous belimumab may be beneficial for patients with SLE who are hypocomplementemic and positive for antibodies against double-stranded DNA, subgroup analyses of a phase III trial suggest.

Osteoporosis (illustration)

12-04-2018 | Osteoporosis | Article | News

Trial results back denosumab as a treatment option for glucocorticoid-induced osteoporosis

Patients with glucocorticoid-induced osteoporosis who are treated with denosumab have greater improvements in bone mineral density than those treated with risedronate, phase III trial results suggest.

Pills in hand

19-03-2018 | Systemic lupus erythematosus | Highlight | News

mTOR inhibition may be an ‘attractive therapeutic option’ for SLE

Results of an open-label phase I/II trial suggest that the mammalian target of rapamycin inhibitor sirolimus has a favorable safety profile and may reduce disease activity in patients with systemic lupus erythematosus.

Hip arthroplasty x-ray

19-12-2017 | Medications | Editorial | Article

Managing antirheumatic medication in patients undergoing elective arthroplasty

Editorial Board member Oliver FitzGerald reviews the recent guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty.

Lisa Sammaritano, Hospital for Special Surgery, New York, USA,

22-05-2020 | Pregnancy | Feature | Article

Reproductive health for rheumatology patients: Dissecting the ACR guideline

Lisa Sammaritano, lead author of the 2020 ACR guideline for reproductive health in patients with rheumatic diseases, talks about why this is a key topic for rheumatologists and explores the importance of cross-disciplinary collaboration.